Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00117156
Status:
COMPLETED
Last Update Posted:
2016-08-01
First Post:
2005-06-30
Brief Title:
Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkins Lymphoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-30
First Submit QC Date:
June 30 2005
Study First Post Date:
2005-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-28
Last Update Post Date:
2016-08-01
Last Update Post Date Type:
ESTIMATED